Skip to content

CareDx CDNA Gross Profit

Discontinued — last reported Q2 '20

Gross Profit at other companies

NeoGenomics logo
NeoGenomicsNEO
$80.86M+10.4%
Personalis, Inc. logo
Personalis, Inc.PSNL
$281K-96.1%
GeneDx Holdings logo
GeneDx HoldingsWGS
$68.21M+16.6%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$101.16M+14.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
Veracyte logo
VeracyteVCYT
$101.16M+27.2%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

The official record: CareDx’s 10-Q, filed July 29, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.